The constant government changes that have taken place over the last three years, along with the general composition of the Knesset (Israel’s parliament) with multiple parties with different ideologies, makes predicting the future of Israel’s CBD sector difficult. CBD is no longer considered a scheduled substance and will be allowed in foods and cosmetics once approved by the Ministry of Health.
A new reform in medical cannabis is expected to enter into force in March 2024, which will ease the regulatory burden for patients and industry members.
This report provides a detailed overview of Israel’s regulatory framework for CBD, hemp and cannabis.